Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Puig-Saus

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Immuno-Oncology Technology|June 27, 2022
Gene editing: Towards the third generation of adoptive T-cell transfer therapiesCristina Puig-Saus, Antoni Ribas
Immunity|December 11, 2024
T-switch-ing TCR specificityAndrew Y Hu, Cristina Puig-Saus
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriersCristina Puig-Saus, Alena Gros, Ramon Alemany, et al.
Human Gene Therapy Methods|September 12, 2013
Adeno-associated virus enhances wild-type and oncolytic adenovirus spreadEduardo Laborda, Cristina Puig-Saus, Manel Cascalló, et al.
The Journal of Experimental Medicine|January 16, 2024
CAR-T cell manufacturing: Major process parameters and next-generation strategiesMelanie Ayala Ceja, Mobina Khericha, Caitlin M Harris, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2014
A pRb-responsive, RGD-modified, and hyaluronidase-armed canine oncolytic adenovirus for application in veterinary oncologyEduardo Laborda, Cristina Puig-Saus, Alba Rodriguez-García, et al.
Cell Discovery|December 5, 2019
Global alteration of T-lymphocyte metabolism by PD-L1 checkpoint involves a block of de novo nucleoside phosphate synthesisNicolaos Jay Palaskas, Jacob David Garcia, Roksana Shirazi, et al.
Cancer Discovery|June 15, 2018
Immunotherapy Resistance by Inflammation-Induced DedifferentiationArnav Mehta, Yeon Joo Kim, Lidia Robert, et al.
Science (New York, N.Y.)|November 27, 2020
Precise T cell recognition programs designed by transcriptionally linking multiple receptorsJasper Z Williams, Greg M Allen, Devan Shah, et al.
Cancer Research Communications|January 2, 2023
Remodeling of the tumor microenvironment through PAK4 inhibition sensitizes tumors to immune checkpoint blockadeGabriel Abril-Rodríguez, Davis Y Torrejon, Daniel Karin, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Immuno-Oncology Technology|June 27, 2022
Gene editing: Towards the third generation of adoptive T-cell transfer therapiesCristina Puig-Saus, Antoni Ribas
Immunity|December 11, 2024
T-switch-ing TCR specificityAndrew Y Hu, Cristina Puig-Saus
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriersCristina Puig-Saus, Alena Gros, Ramon Alemany, et al.
Human Gene Therapy Methods|September 12, 2013
Adeno-associated virus enhances wild-type and oncolytic adenovirus spreadEduardo Laborda, Cristina Puig-Saus, Manel Cascalló, et al.
The Journal of Experimental Medicine|January 16, 2024
CAR-T cell manufacturing: Major process parameters and next-generation strategiesMelanie Ayala Ceja, Mobina Khericha, Caitlin M Harris, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2014
A pRb-responsive, RGD-modified, and hyaluronidase-armed canine oncolytic adenovirus for application in veterinary oncologyEduardo Laborda, Cristina Puig-Saus, Alba Rodriguez-García, et al.
Cell Discovery|December 5, 2019
Global alteration of T-lymphocyte metabolism by PD-L1 checkpoint involves a block of de novo nucleoside phosphate synthesisNicolaos Jay Palaskas, Jacob David Garcia, Roksana Shirazi, et al.
Cancer Discovery|June 15, 2018
Immunotherapy Resistance by Inflammation-Induced DedifferentiationArnav Mehta, Yeon Joo Kim, Lidia Robert, et al.
Science (New York, N.Y.)|November 27, 2020
Precise T cell recognition programs designed by transcriptionally linking multiple receptorsJasper Z Williams, Greg M Allen, Devan Shah, et al.
Cancer Research Communications|January 2, 2023
Remodeling of the tumor microenvironment through PAK4 inhibition sensitizes tumors to immune checkpoint blockadeGabriel Abril-Rodríguez, Davis Y Torrejon, Daniel Karin, et al.
Pageof 3